Journal History

2013 The inaugural issue was released. Vaccines was published as a quarterly journal.
2015 Vaccines was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1).
Vaccines was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1).
Vaccines was indexed in PubMed—National Library of Medicine (NLM), starting with Volume 1 (Issue 1).
2017 Vaccines announced the first edition of the Travel Awards. The journal Twitter account was established.
2018 Vaccines was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 4 (Issue 1).
2019 Vaccines received its first Impact Factor (4.76). The journal ranks 39/158 (Q1) in the 'Immunology' category and 25/136 (Q1) in the "Medicine, Research & Experimental" category.
2020 Vaccines published its 1000th paper.
Vaccines established the following sections:
-Vaccine Adjuvants
-Attenuated/Inactivated/Live and Vectored Vaccines;
-Clinical Immunology;
-Cellular/Molecular Immunology;
-Pathogens-host Immune Interface;
-Human Papillomavirus Vaccines;
-Hepatitis Virus Vaccines.
2021 Vaccines established the following sections:
-COVID-19 Vaccines and Vaccination;
-Vaccination Optimization;
-DNA and mRNA Vaccines.
2023 The year 2023 marked the 10th Anniversary of Vaccines.

Editor-in-Chief

2013–2019 Editor-in-Chief: Prof. Dr. Diane M. Harper
2019–present Editor-in-Chief: Prof. Dr. Ralph A. Tripp

Section Editor-in-Chief

2019–present Section Editor-in-Chief: Dr. Subbaya Subramanian for the section on Cancer Vaccines and Immunotherapy
Section Editor-in-Chief: Dr. Romain Paillot for the section on Veterinary Vaccines
Section Editor-in-Chief: Prof. Dr. Giuseppe La Torre for the section on Epidemiology
Section Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on Vaccines against (re)emerging and Tropical Infections Diseases
Section Editor-in-Chief: Prof. Dr. Martin F. Bachmann for the section on Therapeutic Vaccines and Antibody Therapeutics
2020–present Section Editor-in-Chief: Dr. Yee-Joo Tan for the section on Hepatitis Virus Vaccines
Section Editor-in-Chief: Prof. Dr. François Meurens for the section on Pathogens-host Immune Interface
Section Editor-in-Chief: Prof. Dr. Hans-Peter Hartung for the section on Cellular/Molecular Immunology
Section Editor-in-Chief: Dr. Eduardo Gomez-Casado for the section on Vaccine Adjuvants
Section Editor-in-Chief: Prof. Dr. Giampiero Girolomoni for the section on Clinical Immunology
Section Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on HIV Vaccines
2021–present Section Editor-in-Chief: Prof. Dr. Luis Martinez-Sobrido for the section on COVID-19 Vaccines and Vaccination
Section Editor-in-Chief: Prof. Dr. Hinh Ly for the section on Innate and Adaptive Immunity in Vaccination
Section Editor-in-Chief: Prof. Dr. Jorge H. Leitão for the section on DNA and mRNA Vaccines
Section Editor-in-Chief: Prof. Dr. Amine A. Kamen for the section on Attenuated/Inactivated/Live and Vectored Vaccines
2021–2023 Section Editor-in-Chief: Dr. Ralph J. DiClemente for the section on Vaccines and Society
2023–present Section Editor-in-Chief: Dr. Pedro Plans-Rubió for the section on Vaccine Efficacy and Safety
Back to TopTop